Free shipping on all orders over $ 500

WZ 811

Cat. No. M2041
WZ 811 Structure
Size Price Availability Quantity
10mg USD 85 In stock
50mg USD 200 In stock
100mg USD 320 In stock
Bulk Inquiry?

Quality Control
Biological Activity

WZ811 is a highly potent competitive antagonist of CXCR4. WZ811 shows subnanomolar potency (EC50 = 0.3 nM) in an affinity binding assay. WZ811 inhibits CXCR4/stromal cell-derived factor-1 (SDF-1)-mediated modulation of cyclic adenosine monophophate (cAMP) levels (EC50 = 1.2 nM). In addition, WZ811 efficiently inhibits SDF-1 induced Matrigel invasion (EC50 = 5.2 nM).

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Chemical Information
Molecular Weight 290.36
Formula C18H18N4
CAS Number 55778-02-4
Purity >99%
Solubility DMSO 30 mg/mL
Storage at -20°C
References

Dipyrimidine amines: a novel class of chemokine receptor type 4 antagonists with high specificity.
Zhu A, et al. J Med Chem. 2010 Dec 23;53(24):8556-68. PMID: 21105715.

Discovery of small molecule CXCR4 antagonists.
Zhan W, et al. J Med Chem. 2007 Nov 15;50(23):5655-64. PMID: 17958344.

Related CXCR Products
GSK1325756

GSK1325756 (Danirixin) is a non-peptide, high affinity, selective and reversible CXCR2 antagonist.

MSX-122

MSX-122 is a novel small molecule and partial CXCR4 antagonist, with potent inhibition of CXCR4/CXCL12 actions (IC50 = 10 nM).

Reparixin

Reparixin is a noncompetitive allosteric inhibitor of IL-8 (CXCL8) activation of CXCR1 and CXCR2 chemokine receptors with IC50 of 1 and 100 nM, respectively.

SB225002

SB225002 is a potent and selective non-peptide inhibitor of CXCR2 with IC50 of 22 nM and >150-fold selectivity over CXCR1 and four other 7-TMRs.

Plerixafor 8HCl

Plerixafor 8HCl (AMD3100 8HCl) is a chemokine receptor antagonist for CXCR4 and CXCL12-mediated chemotaxis with IC50 of 44 nM and 5.7 nM, respectively.

  Catalog
Abmole Inhibitor Catalog 2017




Keywords: WZ 811 supplier, CXCR, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2017 AbMole BioScience. All Rights Reserved.